Organicell Regenerative Medicine, Inc.

OCEL · OTC
Analyze with AI
7/31/2025
4/30/2025
1/31/2025
10/31/2024
Operating Activities
Net Income-$2,072-$1,391-$1,243-$5
Dep. & Amort.$19$16$18-$257
Deferred Tax$0$0$0$62
Stock-Based Comp.$1,750$1,096$1,091$1,619
Change in WC$0$0$0-$1,001
Other Non-Cash$46$136$199-$954
Operating Cash Flow-$257-$143$65-$535
Investing Activities
PP&E Inv.-$23$0$0$9
Net Acquisitions$0$0$0-$741
Inv. Purchases$0$0$0$100
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$45
Investing Cash Flow-$23$0$0-$677
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$500
Stock Repurch.$0$0$0$500
Dividends Paid$0$0$0$0
Other Fin. Act.$14-$35-$2-$221
Financing Cash Flow$14-$35-$2-$221
Forex Effect$0$0$0$0
Net Chg. in Cash-$228-$178$63-$1,099
Supplemental Information
Beg. Cash$542$720$657$1,756
End Cash$314$542$720$657
Free Cash Flow-$280-$143$65-$526